Mymee, Inc., a pioneer in self-evidence-based research for people who struggle with symptoms associated with long COVID and rheumatic autoimmune diseases, ...
PRNewswire/ -- Mymee, Inc., a pioneer in self-evidence-based research for people who struggle with symptoms associated with long COVID and rheumatic...
Since then, published studies now cite that women, who make up the majority of patients with rheumatic autoimmune diseases, respond less to biologics and experience more side effects and that 41% of patients who still have Long COVID after 12 months show rheumatic autoimmune disease biomarkers. - Improvements included substantial decreases in fatigue, one of the most common and hardest to treat symptoms associated with rheumatic autoimmune disease and long COVID. Mymee's research matched over 150 unique symptoms to over 90 unique triggers and clinically tested over 50 types of personalized interventions. In the study, patients used Mymee's self-evidence data platform to draw direct correlations between their symptoms and atypical combinations of sensitivities to their food or environment. Additionally, Mymee was nominated for the 2021 Annual Galien Foundation Awards and received an honorable mention in Fast Company's World Changing Ideas Awards. - Patients used the Mymee adaptive mobile app which is continuously adjusted based on their symptoms and environment. Each patient was provided a dedicated certified health and nutrition coach with intensive training on Mymee's data platform and the special needs of rheumatic autoimmune disease and Long COVID patients managing debilitating symptoms. Patients enrolled in Mymee uncovered sensitivities such as sunflower seed butter, vanilla extract, cinnamon, kale, ginger, probiotics and supplements. The retrospective included patients who had tried the Mediterranean diet, the Autoimmune Protocol Diet or an elimination diet without benefit. "For decades, rheumatologists have stressed that patients with significant disease activity need to be careful with fasting and elimination diets," said Mymee CEO and founder, Mette Dyhrberg. The majority of patients in the study were diagnosed with Lupus (SLE), Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Mixed Connective Tissue Disease or Long COVID. - Statistically significant PROMIS improvements were seen in all ten HRQoL domains assessed: fatigue, anxiety, pain interference, pain intensity, social roles, sleep disturbance, cognitive function, physical function, and ability to manage symptoms.